11.3: B Vitamins, Homocysteine and Cardiovascular Disease

Kansas State University: Human Nutrition · LibreTexts

0%

Contents

    Text

    Size
    100%
    Theme
    Typeface
    Line length
    Spacing

    Read aloud

    How

    Speed: 1×
    Light up
    Highlight

    Symbols: Mulberry Symbols, © 2018–2026 Steve Lee, CC BY-SA 4.0 (licence, the set), the site's own copies.

    From LibreTexts, under CC BY-NC-SA 4.0, as the source states it; its equations are written in TeX, which the PDF shows typeset. This page at LibreTexts.

    11.3: B Vitamins, Homocysteine and Cardiovascular Disease

    Homocysteine is a sulfur-containing, non-proteinogenic (not used for making proteins) amino acid whose structure is shown in the figure below.

    Chemical structure of cysteine, featuring a thiol group (HS), amine (NH2), and carboxylic acid (COOH) functional groups.
    Figure \(\PageIndex{1}\): Structure of homocysteine1

    Elevated circulating homocysteine concentrations have been found in people with cardiovascular disease. Folate, vitamin \(B_6\), and vitamin \(B_{12}\) contribute to the conversion of homocysteine to methionine by providing methyl groups, thereby decreasing homocysteine concentrations, as illustrated in the figure below. Thus, based on these facts, it was hypothesized that intake of these B vitamins may decrease the risk of cardiovascular disease.

    Diagram illustrating the interconversion processes of Folate and Vitamin B12, including methylation pathways and related enzymes.
    Figure \(\PageIndex{2}\): One-carbon metabolism

    Research has found that intake of these B vitamins does decrease circulating homocysteine concentrations. However, most studies have not found that it results in improved cardiovascular disease outcomes2-4. It is debated why B vitamin intake has not resulted in improved outcomes. Some think it is because the studies have not focused on individuals with elevated homocysteine concentrations2, while others believe that homocysteine is a biomarker or indicator of cardiovascular disease, not a causative or contributing factor to cardiovascular disease development3.

    ADAPT \(\PageIndex{1}\)

    References

    1. en.Wikipedia.org/wiki/File:Ho...ne_racemic.png
    2. Abraham J, Cho L. (2010) The homocysteine hypothesis: Still relevant to the prevention and treatment of cardiovascular disease? Cleve Clin J Med 77(12): 911-918.
    3. Cacciapuoti F. (2011) Hyper-homocysteinemia: A novel risk factor or a powerful marker for cardiovascular diseases? pathogenetic and therapeutical uncertainties. J Thromb Thrombolysis 32(1): 82-88.
    4. Martai-Carvajal AJ, Sola J, Lathyris D. (2015) Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 1:CD006612.

    This page titled 11.3: B Vitamins, Homocysteine and Cardiovascular Disease was last modified on Thu, 29 Jan 2026 17:50:22 GMT and is shared under a CC BY-NC-SA 4.0 license and was authored, remixed, and/or curated by Brian Lindshield via source content that was edited to the style and standards of the LibreTexts platform.